Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1992-12-22
|
| pubmed:abstractText |
We investigated the effect of the selective D1 dopamine antagonist, SCH23390, on the establishment of a pipradrol-conditioned place preference (CPP). Among various doses of pipradrol (6.25-75.0 mg/kg, SC), a CPP was established at 25.0 mg/kg. SCH23390 (0.16 mg/kg, IP) blocked the establishment of a CPP by this dose of pipradrol. The results suggest that pipradrol produces a rewarding effect and that this effect may involve activation of D1 dopamine receptors.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0091-3057
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
377-80
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:1359572-Animals,
pubmed-meshheading:1359572-Benzazepines,
pubmed-meshheading:1359572-Conditioning, Operant,
pubmed-meshheading:1359572-Male,
pubmed-meshheading:1359572-Piperidines,
pubmed-meshheading:1359572-Rats,
pubmed-meshheading:1359572-Receptors, Dopamine D1,
pubmed-meshheading:1359572-Reward
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Pipradrol conditioned place preference is blocked by SCH23390.
|
| pubmed:affiliation |
Department of Psychology, McGill University, Montreal, Quebec, Canada.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|